Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...
Objective: To explore the practical path and effectiveness of primary public health services in Dahua Town Health Center, and ...
Decade Resources Ltd. announces that it has acquired the right to earn an 80% undivided interest in 3 mineral claims totaling 2969.58 ha. located approximately 50km north of Kamloops, B.C., within the ...